China has begun
two clinical trials (NYT) of an antiviral drug that may be able to fight the coronavirus, a spokesperson for the drug’s manufacturer said.
The drug, which has been tested without adverse effects on Ebola virus patients, will be given to one group of patients who are severely ill and another group who are hospitalized but not as sick. Researchers also recommend the study of other antivirals to fight the coronavirus, including ones used for HIV, as well as
the malaria drug chloroquine (SCMP). If the coronavirus is not contained, it could join the list of four coronaviruses that have become endemic in humans, or reoccur seasonally like the flu, infectious disease experts
told STAT.